{
  "id": "662f8414d4a4238b",
  "title": "Sangamo Therapeutics Initiates Rolling Submission of BLA to U . S . FDA for ST - 920 in Fabry Disease",
  "description": "20251218T161500Z",
  "content": "",
  "source": "marketscreener.com",
  "source_url": "https://www.marketscreener.com/news/sangamo-therapeutics-initiates-rolling-submission-of-bla-to-u-s-fda-for-st-920-in-fabry-disease-ce7d50dcde88f623",
  "published_at": "20251218T161500Z",
  "fetched_at": "2025-12-19T00:23:08.544189+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "fab"
  ],
  "location": "",
  "raw_data": {
    "url": "https://www.marketscreener.com/news/sangamo-therapeutics-initiates-rolling-submission-of-bla-to-u-s-fda-for-st-920-in-fabry-disease-ce7d50dcde88f623",
    "url_mobile": "",
    "title": "Sangamo Therapeutics Initiates Rolling Submission of BLA to U . S . FDA for ST - 920 in Fabry Disease",
    "seendate": "20251218T161500Z",
    "socialimage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
    "domain": "marketscreener.com",
    "language": "English",
    "sourcecountry": ""
  }
}